RhoA: A therapeutic target for chronic myeloid leukemia Full Text
Molecular Cancer, 05/11/2012
Molli PR et al. – RhoA has emerged as the key molecule responsible for functional defects in Chronic Myeloid Leukemia (CML) PMNL and therefore, it can be used a therapeutic target in CML.



